Physician profile
Frank Tilli
NPI 1154321990
$2,355.22
in general payments reported to CMS, 2019-2025
20 companies · $690 in 2025
The $690 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $161 · 2021: $173 · 2022: $298 · 2023: $119 · 2024: $282 · 2025: $690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,055 · Travel and Lodging: $36.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,054.54 |
| Travel and Lodging | $36.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $756.43 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia, Edwards Intuity Elite Valve System |
| Abiomed | $514.30 | 2019-2025 | Impella |
| Abbott Laboratories | $459.06 | 2019-2025 | Amplatzer Amulet, Pressurewire, Mitraclip |
| Boston Scientific Corporation | $195.99 | 2022-2025 | Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $68.56 | 2020 | |
| Heartflow, INC. | $52.78 | 2022 | |
| Novartis Pharmaceuticals Corporation | $51.89 | 2019-2022 | |
| Lundbeck LLC | $41.52 | 2019 | |
| Amgen INC. | $35.89 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $32.21 | 2022 | |
| Cordis US Corp. | $26.50 | 2025 | Mynx Control Venous |
| Pfizer INC. | $24.28 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $22.36 | 2019 | |
| Cardiva Medical, INC. | $16.75 | 2023 | Cardiva Vascade 6/7f Vcs |
| Amarin Pharma, INC. | $16.06 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $14.72 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.33 | 2019 | |
| Medtronic Vascular, INC. | $12.59 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Tilli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.